Impact of lithium treatment on FGF-23 serum concentrations in depressive patients

Journal of Clinical Psychopharmacology

Volumn 34, Issue 6, 2014, Pages 745-747

  Fakhri, Hajar ^a   Ricken, Roland ^b   Adli, Mazda ^b   Fajol, Abul ^a   Walter, Marc ^c   FöLler, Michael ^a   Lang, Florian ^a   Lang, Undine E ^c   Lange, Claudia ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; FIBROBLAST GROWTH FACTOR 23; LITHIUM; PHOSPHATE; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR;

ADULT; CALCIUM BLOOD LEVEL; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT RESPONSE; UPREGULATION; VITAMIN BLOOD LEVEL; BLOOD; DEPRESSIVE DISORDER; FEMALE; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; LITHIUM; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84925659122     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000163     Document Type: Letter

References (23)

1. Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem. 2013;31:761-777.
2. Zhang X, Bao L, Yang L, et al. Roles of intracellular fibroblast growth factors in neural development and functions. Sci China Life Sci. 2012;55:1038-1044.
3. Turner CA, Watson SJ, Akil H. The fibroblast growth factor family: neuromodulation of affective behavior. Neuron. 2012;76:160-174.
4. Heine GH, Seiler S, Fliser D. FGF-23: the rise of a novel cardiovascular risk marker in CKD. Nephrol Dial Transplant. 2012;27:3072-3081.
5. Komaba H, Fukagawa M. The role of FGF23 in CKDVwith or without Klotho. Nat Rev Nephrol. 2012;8:484-490.
6. Gattineni J, Twombley K, Goetz R, et al. Regulation of serum 1,25(OH)2 Vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. Am J Physiol Renal Physiol. 2011;301:F371-F377.
7. Inoue Y, Segawa H, Kaneko I, et al. Role of the vitamin D receptor in FGF23 action on phosphate metabolism. Biochem J. 2005;390:325-331.
8. Shimada T, Mizutani S, Muto T, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A. 2001;98:6500-6505.
9. Marsell R, Jonsson KB. The phosphate regulating hormone fibroblast growth factor-23. Acta Physiol (Oxf). 2010;200:97-106.
10. Fakhri H, Pathare G, Fajol A, et al. Regulation of mineral metabolism by lithium. Pflugers Arch. 2014;466:467-475.
11. Ricken R, Adli M, Lange C, et al. Brain-Derived Neurotrophic Factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants. J Clin Psychopharmacol. 2013;33:806-809.
12. Forlenza OV, de Paula VJ, Machado-Vieira R, et al. Does lithium prevent Alzheimer's disease? Drugs Aging. 2012;29:335-342.
13. Johnson-Farley NN, Patel K, Kim D, et al. Interaction of FGF-2 with IGF-1 and BDNF in stimulating Akt, ERK, and neuronal survival in hippocampal cultures. Brain Res. 2007;1154:40-49.
14. Zarse K, Terao T, Tian J, et al. Low-dose lithium uptake promotes longevity in humans and metazoans. Eur J Nutr. 2011;50:387-389.
15. Sugawara M, Hashimoto K, Ota Z. Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria. Am J Physiol. 1988;254:R863-R869.
16. Pathare G, Föller M, Michael D, et al. Enhanced FGF23 serum concentrations and phosphaturia in gene-targeted mice expressing WNK-resistant Spak. Kidney Blood Press Res. 2012;36:355-364.
17. Brown AJ, Finch J, Slatopolsky E. Differential effects of 19-nor-1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 on intestinal calcium and phosphate transport. J Lab Clin Med. 2002;139:279-284.
18. Rodriguez M, Martinez-Moreno JM, Rodríguez-Otiz ME, et al. Vitamin D and Vascular Calcification in Chronic Kidney Disease. Kidney Blood Press Res. 2011;34:261-268.
19. Kuroo M. Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Nat Rev Nephrol. 2013;9:650-660.
20. Zamani A, Omrani GR, Nasab MM. Lithium's effect on bone mineral density. Bone. 2009;44(2):331-334.
21. Evans SJ, Choudary PV, Neal CR, et al. Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A. 2004;101:15506-15511.
22. Bachis A, Mallei A, Cruz MI, et al. Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons. Neuropharmacol. 2008;55:1114-1120.
23. Maragnoli ME, Fumagalli F, Gennarelli M, et al. Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain. Biol Psychiatry. 2004;55:1095-1102.